ADVERTISEMENT
4 /5 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Consumer Safety

US FDA seeks data on seizures that follow e-cigarette use

by Britt Erickson
April 6, 2019 | APPEARED IN VOLUME 97, ISSUE 14

 

09714-polcon4-ecig.jpg
Credit: Shutterstock

The US Food and Drug Administration is warning consumers about reports of seizures in people, particularly children and young adults, who use e-cigarettes. From 2010 to early 2019, the FDA identified 35 reported cases of seizures after e-cigarette use, the agency announced on April 3. It is too early to tell if e-cigarette use is associated with an increased risk of seizures. “Many of the reports received to date lack enough information to identify a specific brand or sub-brand of e-cigarette. The reports also don’t provide enough detail to establish a clear pattern or cause for these incidents,” FDA commissioner Scott Gottlieb and principal deputy commissioner Amy Abernethy say in a statement. Nonetheless, the FDA wants consumers to be aware of potential safety concerns related to e-cigarette use. The agency is encouraging e-cigarette users to report past and future incidents of seizures and other adverse effects to the agency. The growing use of e-cigarettes by youth has prompted the FDA to reconsider allowing e-cigarettes to remain on the market while manufacturers prepare information to help the agency better understand the health risks of such products.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment